By leveraging our high throughput platform and powerful DynamiQ Insights Engine, we can help sponsors rapidly identify and validate novel biomarkers to subset populations, optimize patient selection, and enhance the safety and efficacy profiles of GLP-1 agents enabling smaller and more successful clinical trials
Ever heard glutathione is the whitening hero Hold upSCIENCE ALERT: Most oral pills DONT work
RAGE: a potential therapeutic target during FGF1 treatment of diabetesmediated liver injury
Beneficiaries with chronic hemodialysis and receiving erythropoietin therapy can receive intravenous iron therapy
Potentially Some animal studies suggest resveratrol might help convert storage fat into more metabolically active fat, but human evidence remains very limited
The SURMOUNT trials showed that 89-91% of participants receiving optimal doses achieved the clinically meaningful 5% weight loss threshold, with many achieving 15% or greater weight reduction